Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Mood stabilizer augmentation with olanzapine in acutely manic children JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY Chang, K. D., Ketter, T. A. 2000; 10 (1): 45-49

Abstract

We report on three cases of acutely manic prepubertal children diagnosed with bipolar disorder who were treated with olanzapine in addition to their existing mood stabilizer regimens. All three had marked improvement of their manic symptoms within 3-5 days of beginning olanzapine therapy as measured by clinician-rated instruments. Adverse effects included sedation and weight gain. These results suggest that olanzapine may have an antimanic or mood stabilizing effect in acutely manic children with bipolar disorder.

View details for Web of Science ID 000085902900007

View details for PubMedID 10755582